SUSQUEHANNA INTERNATIONAL GROUP, LLP - SUMMIT THERAPEUTICS INC ownership

SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 42 filers reported holding SUMMIT THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of SUMMIT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,349,899
+18.5%
721,871
+59.0%
0.00%
Q2 2023$1,139,395
-68.6%
453,942
-78.1%
0.00%
-100.0%
Q1 2023$3,631,189
-44.2%
2,074,965
+35.5%
0.00%
-50.0%
Q4 2022$6,507,277
+6608.5%
1,531,124
+1773.9%
0.00%
Q3 2022$97,000
+304.2%
81,707
+245.7%
0.00%
Q2 2022$24,000
-88.5%
23,637
-69.5%
0.00%
Q4 2021$208,000
-48.3%
77,522
-3.4%
0.00%
Q3 2021$402,000
-49.8%
80,220
-25.2%
0.00%
Q2 2021$800,000
+1.9%
107,300
-19.8%
0.00%
Q1 2021$785,000
+199.6%
133,808
+139.9%
0.00%
Q4 2020$262,00055,7720.00%
Other shareholders
SUMMIT THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Baker Brothers Advisors 6,304,705$15,824,8100.09%
Virtus ETF Advisers LLC 55,763$139,9650.08%
VANCE WEALTH, INC. 39,266$98,5580.04%
CSS LLC/IL 266,514$668,9500.04%
SHELL ASSET MANAGEMENT CO 322,738$8100.03%
Steward Partners Investment Advisory, LLC 600,000$1,506,0000.02%
Alpine Global Management, LLC 30,000$75,3000.02%
SECTORAL ASSET MANAGEMENT INC 50,000$125,5000.02%
BENDER ROBERT & ASSOCIATES 24,059$60,3880.02%
HoyleCohen, LLC 74,408$186,7650.02%
View complete list of SUMMIT THERAPEUTICS INC shareholders